Pluri (NASDAQ:PLUR – Get Free Report) is projected to release its results after the market closes on Wednesday, September 23rd. Analysts expect Pluri to post earnings of ($0.66) per share and revenue of $0.6550 million for the quarter.
Pluri (NASDAQ:PLUR – Get Free Report) last released its quarterly earnings data on Thursday, September 10th. The company reported ($0.54) EPS for the quarter, beating the consensus estimate of ($0.66) by $0.12. The business had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.66 million.
Pluri Price Performance
NASDAQ PLUR opened at $1.08 on Monday. The company has a fifty day moving average of $1.57 and a two-hundred day moving average of $2.41. The firm has a market capitalization of $13.34 million, a price-to-earnings ratio of -0.44 and a beta of 0.68. Pluri has a 52 week low of $1.02 and a 52 week high of $4.87.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Pluri
About Pluri
Pluri Ltd. is an Israel-based biotechnology company that develops cell-based products using its proprietary three-dimensional cell expansion technology. The platform is designed to produce large quantities of potentially therapeutic and commercial cells while maintaining consistent quality and scalability.
The company’s research and development activities have included placenta-derived, off-the-shelf cell therapies, historically marketed under the PLX platform. These programs have targeted areas such as regenerative medicine, inflammation, cancer, orthopedic conditions and other medical needs.
Featured Stories
- Five stocks we like better than Pluri
- NVIDIA Just Named AI’s Next Bottleneck—And These 3 Stocks Sit Right In It
- Gold Has Gone Sideways, But These 3 Stocks Haven’t
- The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing In
- These 3 Stocks Under $20 Have Wall Street Looking Past the Share Price
Receive News & Ratings for Pluri Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pluri and related companies with MarketBeat.com's FREE daily email newsletter.
